• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

变构调节剂:新一代受体拮抗剂。

Allosteric modulators: the new generation of receptor antagonist.

作者信息

Kenakin Terry

机构信息

Assay Development and Compound Profiling, GlaxoSmithKline Research and Development, Research Triangle Park, NC 27709, USA.

出版信息

Mol Interv. 2004 Aug;4(4):222-9. doi: 10.1124/mi.4.4.6.

DOI:10.1124/mi.4.4.6
PMID:15304558
Abstract

Allosteric antagonists modulate the affinity and/or efficacy of agonists for receptors. Although the manner in which this modulation can occur can mimic that of simple competitive antagonists, allosteric antagonists possess unique properties that can present seemingly capricious profiles of antagonism. These unique properties also offer potentially useful patterns for therapeutic utility. This review summarizes methods to detect allosteric antagonism and some special properties of these receptor modulators.

摘要

变构拮抗剂可调节激动剂对受体的亲和力和/或效能。尽管这种调节发生的方式可能类似于简单竞争性拮抗剂,但变构拮抗剂具有独特的性质,可能呈现出看似多变的拮抗作用特征。这些独特性质也为治疗应用提供了潜在有用的模式。本综述总结了检测变构拮抗作用的方法以及这些受体调节剂的一些特殊性质。

相似文献

1
Allosteric modulators: the new generation of receptor antagonist.变构调节剂:新一代受体拮抗剂。
Mol Interv. 2004 Aug;4(4):222-9. doi: 10.1124/mi.4.4.6.
2
Allosteric modulators of metabotropic glutamate receptors: lessons learnt from mGlu1, mGlu2 and mGlu5 potentiators and antagonists.代谢型谷氨酸受体的变构调节剂:从mGlu1、mGlu2和mGlu5增强剂及拮抗剂中获得的经验教训。
Biochem Soc Trans. 2004 Nov;32(Pt 5):881-7. doi: 10.1042/BST0320881.
3
Allosteric properties of G protein-coupled receptor oligomers.G蛋白偶联受体寡聚体的变构特性。
Pharmacol Ther. 2007 Sep;115(3):410-8. doi: 10.1016/j.pharmthera.2007.06.004. Epub 2007 Jun 27.
4
Screening for positive allosteric modulators of biological targets.生物靶点正构变构调节剂的筛选。
Drug Discov Today. 2006 Jul;11(13-14):632-9. doi: 10.1016/j.drudis.2006.05.010.
5
Positive and negative allosteric modulation of metabotropic glutamate receptors: emerging therapeutic potential.代谢型谷氨酸受体的正性和负性变构调节:新出现的治疗潜力。
Pharmacol Ther. 2004 Dec;104(3):233-44. doi: 10.1016/j.pharmthera.2004.08.010.
6
Seven transmembrane receptors as nature's prototype allosteric protein: de-emphasizing the geography of binding.作为自然界原型变构蛋白的七跨膜受体:弱化结合的空间定位
Mol Pharmacol. 2008 Sep;74(3):541-3. doi: 10.1124/mol.108.050062. Epub 2008 Jun 26.
7
Allosteric ligands for the corticotropin releasing factor type 1 receptor modulate conformational states involved in receptor activation.促肾上腺皮质激素释放因子1型受体的变构配体可调节受体激活过程中涉及的构象状态。
Mol Pharmacol. 2008 May;73(5):1371-80. doi: 10.1124/mol.107.042978. Epub 2008 Jan 31.
8
[The endogenous allosteric regulators of receptors].[受体的内源性变构调节剂]
Usp Fiziol Nauk. 2004 Apr-Jun;35(2):73-91.
9
Allosteric enhancers, allosteric agonists and ago-allosteric modulators: where do they bind and how do they act?变构增强剂、变构激动剂和前变构调节剂:它们结合于何处以及如何发挥作用?
Trends Pharmacol Sci. 2007 Aug;28(8):366-73. doi: 10.1016/j.tips.2007.06.008. Epub 2007 Jul 13.
10
Allosteric GPCR modulators: taking advantage of permissive receptor pharmacology.变构G蛋白偶联受体调节剂:利用宽松的受体药理学特性
Trends Pharmacol Sci. 2007 Aug;28(8):382-9. doi: 10.1016/j.tips.2007.06.004. Epub 2007 Jul 13.

引用本文的文献

1
Landscape of Preterm Birth Therapeutics and a Path Forward.早产治疗的现状与未来发展方向
J Clin Med. 2021 Jun 29;10(13):2912. doi: 10.3390/jcm10132912.
2
Allostery of atypical modulators at oligomeric G protein-coupled receptors.寡聚 G 蛋白偶联受体中非典型调节剂的变构调节。
Sci Rep. 2021 Apr 29;11(1):9265. doi: 10.1038/s41598-021-88399-x.
3
Allosteric Modulation of GPCRs: New Insights and Potential Utility for Treatment of Schizophrenia and Other CNS Disorders.G蛋白偶联受体的变构调节:治疗精神分裂症和其他中枢神经系统疾病的新见解及潜在应用
Neuron. 2017 May 3;94(3):431-446. doi: 10.1016/j.neuron.2017.03.016.
4
Allosteric modulation in monomers and oligomers of a G protein-coupled receptor.G蛋白偶联受体单体和寡聚体中的变构调节
Elife. 2016 May 6;5:e11685. doi: 10.7554/eLife.11685.
5
Discovery of a Novel Class of Negative Allosteric Modulator of the Dopamine D2 Receptor Through Fragmentation of a Bitopic Ligand.通过双位点配体片段化发现一类新型多巴胺D2受体负变构调节剂
J Med Chem. 2015 Sep 10;58(17):6819-43. doi: 10.1021/acs.jmedchem.5b00585. Epub 2015 Aug 28.
6
Inhibition and Reversal of Microbial Attachment by an Antibody with Parasteric Activity against the FimH Adhesin of Uropathogenic E. coli.一种对致病性大肠杆菌FimH黏附素具有副位活性的抗体对微生物黏附的抑制和逆转作用
PLoS Pathog. 2015 May 14;11(5):e1004857. doi: 10.1371/journal.ppat.1004857. eCollection 2015 May.
7
Opportunities and challenges in the discovery of allosteric modulators of GPCRs for treating CNS disorders.发现用于治疗中枢神经系统疾病的GPCR变构调节剂的机遇与挑战。
Nat Rev Drug Discov. 2014 Sep;13(9):692-708. doi: 10.1038/nrd4308.
8
Synthesis and evaluation of candidate PET radioligands for corticotropin-releasing factor type-1 receptors.促肾上腺皮质激素释放因子1型受体候选正电子发射断层显像放射性配体的合成与评价
Nucl Med Biol. 2014 Jul;41(6):524-35. doi: 10.1016/j.nucmedbio.2014.03.005. Epub 2014 Mar 29.
9
Structure-based ligand discovery targeting orthosteric and allosteric pockets of dopamine receptors.基于结构的配体发现,针对多巴胺受体的正构和变构口袋。
Mol Pharmacol. 2013 Dec;84(6):794-807. doi: 10.1124/mol.113.088054. Epub 2013 Sep 10.
10
Transmitted/founder and chronic HIV-1 envelope proteins are distinguished by differential utilization of CCR5.传播/创始型和慢性 HIV-1 包膜蛋白通过 CCR5 的不同利用来区分。
J Virol. 2013 Mar;87(5):2401-11. doi: 10.1128/JVI.02964-12. Epub 2012 Dec 26.